Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection

Blood

Volumn 126, Issue 18, 2015, Pages 2153-2161

  Price, Thomas H ^a,b   Boeckh, Michael ^a,c   Harrison, Ryan W ^d   McCullough, Jeffrey ^e   Ness, Paul M ^f   Strauss, Ronald G ^g   Nichols, W Garrett ^c,h   Hamza, Taye H ^d   Cushing, Melissa M ⁱ   King, Karen E ^f   Young, Jo Anne H ^e   Williams, Eliot ^j   McFarland, Janice ^k   Chakrabarty, Jennifer Holter ^l   Sloan, Steven R ^m   Friedman, David ⁿ   Parekh, Samir ^o   Sachais, Bruce S ^p,q   Kiss, Joseph E ^r,s   Assmann, Susan F ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BloodWorks Northwest   (United States)

^c USA   (United States)

^d NEW ENGLAND RESEARCH INSTITUTES   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^h Chimerix Inc   (United States)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

^j UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^k BLOOD RESEARCH INSTITUTE   (United States)

^l UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^m BOSTON CHILDREN S HOSPITAL   (United States)

ⁿ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^o MONTEFIORE MEDICAL CENTER   (United States)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

^q NEW YORK BLOOD CENTER   (United States)

^r UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^s INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; ANTIINFECTIVE AGENT; GLUCOCORTICOID;

ADULT; ALLERGIC REACTION; ANTIMICROBIAL THERAPY; BLOOD PRESSURE; BLOOD TRANSFUSION REACTION; CHILL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FEVER; GRANULOCYTE; GRANULOCYTE TRANSFUSION; HUMAN; HYPOTENSION; HYPOXIA; INFECTION; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; NEUTROPHIL COUNT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TACHYCARDIA; TREATMENT OUTCOME; CLINICAL TRIAL; COMPLICATION; CYTOLOGY; DRUG EFFECTS; LEUKOCYTE COUNT; LEUKOCYTE TRANSFUSION; PROCEDURES;

ANTI-INFECTIVE AGENTS; DEXAMETHASONE; GLUCOCORTICOIDS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; INFECTION; LEUKOCYTE COUNT; LEUKOCYTE TRANSFUSION; NEUTROPENIA; TREATMENT OUTCOME;

EID: 84945950094     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-05-645986     Document Type: Conference Paper

References (46)

1. Grow WB, Moreb JS, Roque D, et al. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant. 2002;29(1):15-19.
2. Marr KA, Schlamm HT, Herbrecht R, et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. 2015;162(2):81-89.
3. Wingard JR, Carter SL, Walsh TJ, et al; Blood and Marrow Transplant Clinical Trials Network. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood. 2010;116(24):5111-5118.
4. Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med. 2007;356(4):335-347.
5. Robenshtok E, Gafter-Gvili A, Goldberg E, et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol. 2007;25(34): 5471-5489.
6. Miles-Jay A, Butler-Wu S, Rowhani-Rahbar A, Pergam SA. Incidence rate of fluoroquinoloneresistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplantation patients during an era of levofloxacin prophylaxis. Biol Blood Marrow Transplant. 2015;21(3): 539-545.
7. El-Mahallawy HA, El-Wakil M, Moneer MM, Shalaby L. Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer. Pediatr Blood Cancer. 2011;57(2):283-288.
8. Xu ZQ, Flavin MT, Flavin J. Combating multidrugresistant Gram-negative bacterial infections. Expert Opin Investig Drugs. 2014;23(2):163-182.
9. Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood. 1993;81(7):1675-1678.
10. Vallejos C, McCredie KB, Bodey GP, Hester JP, Freireich EJ. White blood cell transfusions for control of infections in neutropenic patients. Transfusion. 1975;15(1):28-33.
11. Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med. 1981; 304(20):1185-1189.
12. Karp DD, Ervin TJ, Tuttle S, Gorgone BC, Lavin P, Yunis EJ. Pulmonary complications during granulocyte transfusions: incidence and clinical features. Vox Sang. 1982;42(2):57-61.
13. Winston DJ, Ho WG, Howell CL, et al. Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med. 1980; 93(5):671-675.
14. Hersman J, Meyers JD, Thomas ED, Buckner CD, Clift R. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med. 1982;96(2):149-152.
15. Morse EE, Freireich EJ, Carbone PP, et al. The transfusion of leukocytes from donors with chronic myelocytic leukemia to patients with leukopenia. Transfusion. 1966;6:183-192.
16. Lowenthal RM, Grossman L, Goldman JM, et al. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia. Lancet. 1975;1(7903):353-358.
17. Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apher. 1996;11(1):1-9.
18. Stanworth SJ, Massey E, Hyde C, et al. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev. 2005;(3):CD005339.
19. Appelbaum FR, Bowles CA, Makuch RW, Deisseroth AB. Granulocyte transfusion therapy of experimental Pseudomonas septicemia: study of cell dose and collection technique. Blood. 1978; 52(2):323-331.
20. Epstein RB, Chow HS. An analysis of quantitative relationships of granulocyte transfusion therapy in canines. Transfusion. 1981;21(3):360-362.
21. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA. Neutrophil kinetics in man. J Clin Invest. 1976;58(3):705-715.
22. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood. 1993;81(7):1883-1888.
23. Hester JP, Dignani MC, Anaissie EJ, Kantarjian HM, O'Brien S, Freireich EJ. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apher. 1995;10(4): 188-193.
24. Leitman SF, Yu M, Lekstrom J. Pair-controlled study of granulocyte colony-stimulating factor (G-CSF) plus dexamethasone (DEXA) for granulocytapheresis donors [abstract]. Transfusion. 1995;35(suppl):53S.
25. Grigg A, Vecchi L, Bardy P, Szer J. G-CSF stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis. Aust N Z J Med. 1996;26(6):813-818.
26. Adkins D, Spitzer G, Johnston M, Velasquez W, Dunphy F, Petruska P. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion. 1997;37(7):737-748.
27. Peters C, Minkov M, Matthes-Martin S, et al. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol. 1999;106(3): 689-696.
28. Price TH, Bowden RA, Boeckh M, et al. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood. 2000;95(11):3302-3309.
29. Kerr JP, Liakopolou E, Brown J, et al. The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. Br J Haematol. 2003;123(1):114-118.
30. Rutella S, Pierelli L, Sica S, et al. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors. Cytotherapy. 2003;5(1):19-30.
31. Lee JJ, Song HC, Chung IJ, Bom HS, Cho D, Kim HJ. Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections. Haematologica. 2004;89(5):632-633.
32. Safdar A, Hanna HA, Boktour M, et al. Impact of high-dose granulocyte tranfusions in patients with cancer with candidemia: retrospective casecontrol analysis of 491 episodes of Candida species bloodstream infections. Cancer. 2004; 101(12):2859-2865.
33. Mousset S, Hermann S, Klein SA, et al. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol. 2005;84(11): 734-741.
34. Grigull L, Pulver N, Goudeva L, et al. G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer. 2006;14(9):910-916.
35. Dale DC, Liles WC, Llewellyn C, Rodger E, Price TH. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone. Transfusion. 1998;38(8): 713-721.
36. Adkins D, Goodgold H, Hendershott L, Johnston M, Cravens D, Spitzer G. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1997;19(8): 809-812.
37. Illerhaus G, Wirth K, Dwenger A, et al. Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions. Ann Hematol. 2002;81(5):273-281.
38. Nichols WG, Strauss R, Ambruso D, et al. G-CSF-stimulated granulocyte transfusions from unrelated community donors for severe infections during neutropenia; a phase II multicenter trial of feasibility and efficacy. Blood. 2003;102(11):978a.
39. Hübel K, Carter RA, Liles WC, et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion. 2002;42(11):1414-1421.
40. Seidel MG, Peters C, Wacker A, et al. Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant. 2008;42(10):679-684.
41. De Pauw B, Walsh TJ, Donnelly JP, et al; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-1821.
42. Zelen M. The randomization and stratification of patients to clinical trials. J Chronic Dis. 1974; 27(7-8):365-375.
43. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6): 649-655.
44. Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007;356(4):348-359.
45. van Burik JA, Ratanatharathorn V, Stepan DE, et al; National Institute of Allergy and Infectious Diseases Mycoses Study Group. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis. 2004;39(10): 1407-1416.
46. Arvanitis M, Anagnostou T, Fuchs BB, Caliendo AM, Mylonakis E. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014;27(3):490-526.